Literature DB >> 1938539

Accelerated repopulation: friend or foe? Exploiting changes in tumor growth characteristics to improve the "efficiency" of radiotherapy.

L B Marks1, M Dewhirst.   

Abstract

Accelerated repopulation (rapid multiplication of surviving clonogens) during a course of radiation therapy may contribute to local failure. This possibility has prompted accelerated treatment programs in an attempt to reduce overall treatment time, thereby minimizing the impact of repopulation. However, accelerated dose delivery at the start of treatment may not be advantageous since many of the tumor cells are likely to be hypoxic (non-cycling cells) and therefore relatively radioresistant. Conversely, accelerated treatment is likely to be most helpful later in treatment when the tumor has shrunk and accelerated repopulation of clonogens is a dominant factor. A series of calculations are presented that stimulate changes in tumor size, clonogen number, clonogen repopulation, and growth fraction during a course of fractionated radiation treatments for an idealized 2 cm diameter spherical tumor. The efficiency of each fraction of radiation is calculated for different radiation fractionation schemes. Efficiency is defined as the change in Log clonogen number (reflecting cell death due to radiation minus repopulation that has occurred during the interval between fractions) per Gy. These calculations suggest that relatively low total daily doses (approximately 2 Gy) are most efficient early in treatment. Higher daily doses are less efficient since the growth fraction is relatively low at the start of treatment. Later in treatment, as the tumor shrinks and the growth fraction approaches 1, accelerated repopulation becomes a major problem and higher total daily doses are more efficient. At this point, accelerated hyperfractionation should be used to increase the daily dose without exposing normal tissues to high fraction sizes. Thus, changes in tumor growth characteristics are exploited and dose delivery can be optimized by escalating daily irradiation doses during a course of fractionated irradiation. Strict interpretation of these conclusions must be tempered by the various assumptions and uncertainties included in this model. The concept of efficiency is useful since it reflects the competing effects of clonogen repopulation and radiation induced clonogen sterilization.

Entities:  

Mesh:

Year:  1991        PMID: 1938539     DOI: 10.1016/0360-3016(91)90301-j

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

Review 1.  Cell death-stimulated cell proliferation: a tissue regeneration mechanism usurped by tumors during radiotherapy.

Authors:  Mary A Zimmerman; Qian Huang; Fang Li; Xinjiang Liu; Chuan-Yuan Li
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

2.  In silico simulation of the effect of hypoxia on MCF-7 cell cycle kinetics under fractionated radiotherapy.

Authors:  Adrian S Remigio
Journal:  J Biol Phys       Date:  2021-09-17       Impact factor: 1.560

3.  Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase 1 inhibition.

Authors:  Jenny Ling-Yu Chen; Jo-Pai Chen; Yu-Sen Huang; Yuan-Chun Tsai; Ming-Hsien Tsai; Fu-Shan Jaw; Jason Chia-Hsien Cheng; Sung-Hsin Kuo; Ming-Jium Shieh
Journal:  Strahlenther Onkol       Date:  2016-03-07       Impact factor: 3.621

Review 4.  Bringing the heavy: carbon ion therapy in the radiobiological and clinical context.

Authors:  Cody D Schlaff; Andra Krauze; Arnaud Belard; John J O'Connell; Kevin A Camphausen
Journal:  Radiat Oncol       Date:  2014-03-28       Impact factor: 3.481

5.  A prospective study: current problems in radiotherapy for nasopharyngeal carcinoma in yogyakarta, indonesia.

Authors:  Sharon D Stoker; Maarten A Wildeman; Renske Fles; Sagung R Indrasari; Camelia Herdini; Pieter L Wildeman; Judi N A van Diessen; Maesadji Tjokronagoro; I Bing Tan
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

6.  Ionizing radiation, ion transports, and radioresistance of cancer cells.

Authors:  Stephan M Huber; Lena Butz; Benjamin Stegen; Dominik Klumpp; Norbert Braun; Peter Ruth; Franziska Eckert
Journal:  Front Physiol       Date:  2013-08-14       Impact factor: 4.566

7.  The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study.

Authors:  S D Stoker; R Fles; C Herdini; F J F Rijntjes; M Tjokronagoro; S R Dwidanarti; K Sikorska; C R Leemans; M K Schmidt; A Al-Mamgani; M A Wildeman; S M Haryana; S R Indrasari; I B Tan
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

8.  Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity-modulated radiation therapy era.

Authors:  Xing-Li Yang; Guan-Qun Zhou; Li Lin; Lu-Lu Zhang; Fo-Ping Chen; Jia-Wei Lv; Jia Kou; Dan-Wan Wen; Jun Ma; Ying Sun; Yan-Ping Mao
Journal:  Cancer Med       Date:  2020-10-27       Impact factor: 4.452

9.  A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol.

Authors:  Alexie J Baja; Krista L Kelsey; David M Ruslander; Tracy L Gieger; Michael W Nolan
Journal:  Vet Comp Oncol       Date:  2022-04-03       Impact factor: 2.385

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.